Viewing Study NCT00779233


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-03-07 @ 9:27 PM
Study NCT ID: NCT00779233
Status: COMPLETED
Last Update Posted: 2008-10-24
First Post: 2008-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions
Sponsor: Ranbaxy Laboratories Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module